Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Ashburton Jersey Ltd

Ashburton Jersey Ltd boosted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 6.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,307 shares of the biotechnology company’s stock after purchasing an additional 988 shares during the period. Axon Enterprise makes up 1.8% of Ashburton Jersey Ltd’s portfolio, making the stock its 16th biggest position. Ashburton Jersey Ltd’s holdings in Axon Enterprise were worth $3,954,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AXON. Westfield Capital Management Co. LP boosted its stake in shares of Axon Enterprise by 184.3% during the 3rd quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after buying an additional 451,350 shares during the last quarter. Vaughan Nelson Investment Management L.P. grew its holdings in Axon Enterprise by 18.4% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 104,587 shares of the biotechnology company’s stock worth $27,019,000 after acquiring an additional 16,230 shares in the last quarter. BKM Wealth Management LLC acquired a new position in Axon Enterprise during the 4th quarter worth $32,000. Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of Axon Enterprise by 0.3% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 147,345 shares of the biotechnology company’s stock worth $29,320,000 after purchasing an additional 495 shares during the last quarter. Finally, International Assets Investment Management LLC bought a new position in shares of Axon Enterprise during the fourth quarter worth about $39,907,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on AXON shares. JPMorgan Chase & Co. boosted their price objective on Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. Robert W. Baird upped their price target on Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a research report on Thursday, February 22nd. JMP Securities raised their price objective on Axon Enterprise from $320.00 to $375.00 and gave the stock a “market outperform” rating in a research note on Wednesday. StockNews.com downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. Finally, Barclays raised their target price on shares of Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a report on Thursday, February 29th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $323.09.

Axon Enterprise Stock Performance

Axon Enterprise stock traded up $4.10 during mid-day trading on Thursday, hitting $315.67. 142,401 shares of the company’s stock traded hands, compared to its average volume of 466,115. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87. The firm has a 50 day moving average price of $306.97 and a 200 day moving average price of $263.93. The company has a market cap of $23.82 billion, a PE ratio of 135.47 and a beta of 0.91.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.29. The business had revenue of $432.14 million during the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. On average, equities analysts forecast that Axon Enterprise, Inc. will post 2.44 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.